The relationship between RSV bronchiolitis and the development of asthma

Harefuah

Volumn 146, Issue 6, 2007, Pages 480-484

  Mahamid, Jamal ^a   Armoni, Michael ^b,c   Bibi, Haim ^d  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

Acute bronchiolitis; Airway hyper responsiveness; Asthma; Respiratory Syncytial Virus (RSV)

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ABNORMAL RESPIRATORY SOUND; ASTHMA; BRONCHIOLITIS; HUMAN; PHYSIOLOGY; RESPIRATORY TRACT DISEASE; REVIEW; ROUS SARCOMA ONCOVIRUS; VIROLOGY;

ASTHMA; BRONCHIOLITIS; FIBROBLAST GROWTH FACTOR 2; HUMANS; RESPIRATORY SOUNDS; RESPIRATORY TRACT DISEASES; ROUS SARCOMA VIRUS;

EID: 34548826253     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Ogra PL, Respuratory Syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev, 2004; 5: (Suppl A) S119-S126.
2. Tripp RA, Pathogenesis of respiratory syncytial virus infection. Viral Immunol, 2004; 17: 165-181.
3. Kalina WV & Gershwin LJ, Progress in defining the role of respiratory syncytial virus in allergy and asthma: from clinical observation to animal models. Clin Dev Immunol, 2004; 11: 113-119.
4. Sigurs N, Epidemiology and clinical evidence of respiratory syncytial virus reactive airway disease link. Am J Respir Crit Car Med, 2001; 163: S2-S6.
5. Simoes AF, Respiratory syncytial virus. Lancet, 1999; 354: 847-852.
6. Witting HJ & Glaser J, The relationship between acute bronchiolitis and childhood asthma. J Allerg, 1959; 30: 19-23.
7. Eisen A & Bacal HL, The relationship of acute bronchiolitis and bronchial asthma; a 4-14 years follow up. Pediatrics, 1963; 31: 859-861.
8. Roony JC & Williams HE, The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr, 1971; 79: 744-747.
9. Kneybert MLJ, Steyerberg EW, de Groot R & al, Long-term effect of respiratory syncytial virus (RSV) bronchiolitis in infant and young children: a quantative review. Acta Paediatr, 2000; 89: 654-660.
10. Stein RT, Sherrill D, Morgan WJ & al, Respiratory syncytial virus in early life and risk of wheezing and allergy by age 13 years. Lancet, 1999; 354: 541-545.
11. Sigrus N, Bjarson R, Sigurbergsson F & al, Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respirt Crit Care Med, 2000; 161: 1501-1507.
12. Sigurs N, Gustatsson PM, Bjarnson R & al, Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med, 2005; 171: 137-141.
13. Milner AD, Swarbrick AS, Alexander J & al, Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child, 1997; 76: 315-9.
14. Kroppi M, Piippo-Savolainen E, Korhonen K & al, Respiratory morbidity 20 Years after respiratory syncytial virus infection in infancy. Pediatr Pulmonol, 2004; 38: 155-166.
15. Dakhama A, Park JW, Taube C & al, The role of virus- specific Immunoglobulin E in Airway Hyperresponsivness. Am J Respir Crit Care Med, 2004; 170: 952-959.
16. Pifferi M, Ragazzo V, Caramella D & al, Eosinophil cationic protein in infant with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pediatr Pulmonol, 2001; 31: 419-24.
17. Volovitz B, Welliver RC, De Castro G & al, The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res, 1988; 24: 504-7.
18. Dosaujh A, Redman S & Martin M, Respiratory syncytial virus augments production of fibroblast growth factor basic in vitro: implications for a possible mechanism of prolonged wheezing after infection. Pediatr Allergy Immunol, 2003; 14: 437-440.
19. Hegle RG, Hayashi S, Bramley AM & al, Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea Pigs. Chest, 1994; 105: 1848-1854.
20. Piedimonte G, Hegele RG & Auais A, Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatr Res, 2004; 55: 657-565.
21. Bramley AM, Vitalis TZ, Wiggs BR & al, Effect of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs. Eur Respir J, 1999; 14: 1061-1067.
22. Piedimonte G, Contribution of neuroimmune mechanism to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J, 2003; 22: S66-74.
23. Dakhama A, Park JW, Taube C & al, Alternation of airway sensory neuropeptide expression and development of airway hyperresponsivness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol, 2005; 288: L761-770.
24. Kerr MH & Paton JY, Surfactant protein levels in severe respiratory syncytial virus infection. Am J Respir Crit Care Med, 1999; 159: 1115-1118.
25. Van Shaik SM, Vargas I, Welliver RC & al, Surfactant dysfunction develops in BALB/c mice infected with respiratory syncytial virus. Paediatr Res, 1997; 42: 169-173.
26. Tibby SM, Hatherill M, Wright SM & al, Exogenous surfactant supplementation in infancy with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med, 2000; 162: 1251-1256.
27. Luchetti M, Ferro F, Gallini C & al, Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus induced respiratory failure. Pediatr Crit Care Med, 2002; 3: 261-268.
28. Tal G, Mendelberg A, Cesar K & al, Association between common Toll-like syncytial virus disease. Receptor 4 mutations and severe respiratory. Infect Dis, 2004; 189: 2057-63.
29. Hull J, Thomson A & Kwiatkowski D, Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax, 2000; 55: 1023-7.
30. Prescott SL, Macuubas C, Smallacombe T & al, Development of an allergen specific T-cell memory in atopic and normal children. Lancet, 1999; 353: 196-200.
31. Welliver RC, Wong DT, Sun M & al, The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med, 1981; 305: 841-6.
32. De Alarcon A, Walsh EE, Carper HT & al, Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infant with wheezing. J Pediatr, 2001; 138: 311-317.
33. Aoyagi M, Shimojo N, Sekine EK & al, Respiratory syncytial virus infection suppress IFN-gamma production of gamma delta T cells. Clin Exp Immunol, 2003; 131: 197-198.
34. Bendelja K, Gargo A, Bace A & al, Predominant Type -2-response in infant with respiratory syncytial virus infection demonstrated by flow cytometrey. Clin Exp Immunol, 2000; 12: 332-338.
35. Kim CK, Kim SW, Park CS & al, Bronchoalveolar lavage cytokine profile in acute bronchiolitis. J Allergy Clin Immunol, 2003; 112: 64-71.
36. Scwarze J, Cieslewiccz G, Hamelmann E & al, IL-5 and eosinophils are essential for the development of AHR following acute respiratory syncytial virus infection. J Immunol, 1999; 162: 2997-3004.
37. Peebles RSJ, Sheller JR, Collins RD & al, Respiratory syncytial virus infection does not increase allergic-induced Type 2 cytokine production, yet increase airway hyperresponsiveness in mice. J Med Virol, 2001; 63: 178-88.
38. Lukacs NW, Tekkanat KK, Berlin A & al, Respiratory syncytial virus predispose to augmented allergic airway response via IL-13 - mediated mechanism. J Immunol, 15; 167: 1060-1065.
39. Peebles RS Jr, Hashimoto K & Graham BS, The complex relationship between respiratory syncytial virus and allergy in lung disease. Viral Immunol, 2003; 16: 25-34.